mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.008 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.008 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.008 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.008 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.01 |